HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2000, 02, 1 (pages: 9 - 14)

Sexual dysfunction associated with methadone maintenance: Treatment with bromocryptine

Shinderman M. S., Maxwell S.

Summary: Sexual dysfunction, a side effect of methadone maintenance treatment, may be caused by opioid-induced hyperprolactinemia; on this basis, a dopamine agonist could reverse the effect. We treated 34 (23 male; 11 female) patients with bromocryptine, 2.5-10mg/d. 65% of males and 36% of females reported a positive response. Responders and non-responders had a similar age (44 Vs 40 yrs), time in MMT (45.5 mos), and use of serotonergic antidepressant therapy (21.1% Vs 26.7%). Responders took higher doses of methadone (220.3 Vs 165.6 mg/d), and were more likely to be taking bupropion or methylphenidate (42.1% Vs 26.7%). Alternative therapies with other dopaminergic agonists are discussed

 

EUROPAD - European Opiate Addiction Treatment Association
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page